clinical trial · NCT07106788
Aveir Leadless Pacemaker Japan PMS
Abbott Medical Devices·—·recruiting·n = 304
Leadless PacemakerAveir DR Leadless Pacemaker ImplantSingle-chamber atrial Aveir patientsUpgradesRoll-over
brief summary
The primary purpose of the PMS is to collect safety information on the Aveir DR leadless cardiac pacemaker (LP) system in a population indicated for de novo dual-chamber pacing. Additionally, the PMS will collect data on rollover patients from the Aveir DR i2i IDE, Aveir AR LP in patients indicated for single-chamber pacing in the right atrium, and upgradeability in patients implanted with single-chamber Aveir atrial or ventricular LP that require an upgrade to a dual-chamber Aveir LP.
started
May 26, 2025
primary completion
Nov 1, 2029
completion
Nov 1, 2029
last updated
Aug 28, 2025
official title
Aveir Leadless Pacemaker Japan Post Marketing Surveillance
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol